E-LIB Suche - Ergebnisse für: Sokoloff, P.

1

S.04.01 Striatal synaptic and cortical nuclear orphan G pro..:

Massart, R. ; Mignon, V. ; Diaz, J..
European Neuropsychopharmacology. 18 (2008) - p. S160 , 2008

Link: https://doi.org/10.1016/..

2

P.1.25 Striatal synaptic and cortical nuclear orphan G prot..:

Massart, R. ; Guilloux, J.P. ; Mignon, V....
European Neuropsychopharmacology. 18 (2008) - p. s21-s22 , 2008

Link: https://doi.org/10.1016/..

3

Linkage with the Ser9Gly DRD3 polymorphism in essential tre..:

Lucotte, G ; Lagarde, JP ; Funalot, B.
Clinical Genetics. 69 (2006) 5 - p. 437-440 , 2006

Link: https://doi.org/10.1111/..

4

Impact and response of southwest Florida mangroves to the 2..:

Milbrandt, E. C. ; Greenawalt-Boswell, J. M. ; Sokoloff, P. D..
Estuaries and Coasts. 29 (2006) 6 - p. 979-984 , 2006

Link: https://doi.org/10.1007/..

5

Tremblementessentiel et gène du récepteur de la dopamine:

Jeanneteau, F. ; Funalot, B. ; Jankovic, J....
Revue Francophone des Laboratoires. 2006 (2006) 384 - p. 14 , 2006

Link: https://doi.org/10.1016/..

6

Identification and functional assessment of small peptides ..:

Cazorla, M. ; Rose, C. ; Pilon, C...
European Neuropsychopharmacology. 16 (2006) - p. S12-S13 , 2006

Link: https://doi.org/10.1016/..

7

The dopamine D receptor and drug dependence: Effects on rew..:

LEFOLL, B ; GOLDBERG, S ; SOKOLOFF, P
Neuropharmacology. 49 (2005) 4 - p. 525-541 , 2005

Link: https://doi.org/10.1016/..

8

P.1.04 Interactions of GIPC with dopamine D2, D3 but not D4..:

Jeanneteau, F. ; Guillin, O. ; Diaz, J...
European Neuropsychopharmacology. 14 (2004) - p. S5 , 2004

Link: https://doi.org/10.1016/..

9

Ave5997, a dopamine D3 antagonist for the treatment of schi..:

Kongsamut, S. ; Hendrix, J. ; Bordeau, K....
Schizophrenia Research. 60 (2003) 1 - p. 312 , 2003

Link: https://doi.org/10.1016/..

10

S.27.05 Nicotine and dopamine D3 receptor: Implications in ..:

Le Foll, B. ; Diaz, J. ; Schwartz, J.-C..
European Neuropsychopharmacology. 13 (2003) - p. S170 , 2003

Link: https://doi.org/10.1016/..

11

Correction of dizocilpine-induced behavioral and biochemica..:

Leriche, L. ; Diaz, J. ; Schwartz, J.-C..
European Neuropsychopharmacology. 12 (2002) - p. 92 , 2002

Link: https://doi.org/10.1016/..

12

The D3R partial agonist, BP 897, attenuates the discriminat..:

Beardsley, P.M. ; Sokoloff, P. ; Balster, R.L..
Behavioral Pharmacology. 12 (2001) 1 - p. 1-11 , 2001

Link: https://doi.org/10.1097/..

13

BDNF, behavioral sensitization and schizophrenia:

Guillin, O. ; Diaz, J. ; Carroll, P....
European Neuropsychopharmacology. 11 (2001) - p. S150 , 2001

Link: https://doi.org/10.1016/..

14

Dopamine D3 receptor agents in schizophrenia:

Sokoloff, P. ; Diaz, J. ; Pilon, C..
European Neuropsychopharmacology. 9 (1999) - p. 180-181 , 1999

Link: https://doi.org/10.1016/..

15

Role of brain-derived neurotrophic factor in the control of..:

Guillin, O. ; Damier, L. ; Griffon, N....
European Neuropsychopharmacology. 9 (1999) - p. 184-185 , 1999

Link: https://doi.org/10.1016/..